Search

everythinglearnresearchcommunity

for

Search:↓

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Fat cells in the skin help start healing and form important repair cells after injury.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

New guidelines using video aim to ensure honest reporting of hair loss treatments.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Minoxidil decreases LH expression, while hydralazine has mixed effects on prolyl and lysyl hydroxylase activities.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

Minoxidil may cause heart changes; use caution and monitor patients with heart conditions.

Hair restoration surgery has improved with better techniques for natural looks and managing patient expectations, but it remains labor-intensive and requires careful consideration of potential complications.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

The moisturizer with phytol improved skin texture and reduced fine wrinkles better than the moisturizer without it.

Androgens and other hormones affect hair growth and skin conditions like acne.